Total views : 187
Assessment of Foods and Drinks for the Presence of Extended Spectrum Beta Lactamase (ESBL) Producing Bacteria in Gombe Metropolis, Nigeria
Objectives: To make preliminary screening study for the presence of ESBL producing bacteria, in food and drinks sold in Gombe metropolis. 30 samples of food and drinks were collected and analyzed. Method: Bacterial isolation was performed on nutrient agar and identification started from gram staining; the gram negative isolates obtained, among which ESBL producers were found and further subjected to standard biochemical tests and confirmed to be enterobacteriaceae. They were then screened for ESBLs in accordance with Clinical and Laboratory Standard Institute (CLSI) breakpoint, and the suspected ESBLs bacteria were confirmed using double disc synergy testing (DDST) with standard Augmentin (Amoxycillin/ Clavulanic Acid, 30μg; Oxoid England, CT0223B), Ceftriaxone (CRO 30μg; Oxoid England, CT0417B) and Ceftazidime (CAZ 30μg; Oxoid England, CT0412B). Findings: The fourteen 14(100%) Gram negative bacteria isolated were found to include Pseudomonasaeruginosa 2(14.29%) and members of the family Enterobacteriaceae (enteric gram negative rods): Citrobacterfreundii 2(14.29%), Enterobacterspp. 1(7.14%), Escherichiacoli 4(28.57%), Klebsiellapneumoniae 3(21.43%), Proteusvulgaris 1(7.14%) and Salmonellatyphi 1(7.14%). When screened for ESBL production based on CLSI breakpoint, only 6 (49.99%) were positive and included C.freundii 1(7.14%), E.coli 2(14.29%), K.pneumoniae 1(7.14%), S. typhi 1(7.14%) and 1(7.14%) for Ps. aeruginosa. On subjecting them to DDST, only 2(33.34%) out of them were found to be ESBLs positive by an increase in inhibition zone of 5mm toward the centre disc, Augmentin. They include E. coli 1(16.67%) and S. typhi 1(16.67%). Application: In a nutshell, foods and drinks sold therein could serve as reservoirs for ESBLs producing bacteria.
ESBL, Foods and Drinks, Gombe Metropolis, Screening.
- Yusha’u M, Abubakar HM, Kawo AH. Commercial foods as potential sources of Extended Spectrum Beta Lactamases (ESBLs) Producers in Kano, Nigeria. International Journal of Pharmaceutical and Applied Sciences. 2010; (1):59–62.
- George EA, Sankar S, Jesudasan MV, Sudandiradoss C, Nandagopal B. Incidence of extended spectrum beta lactamase producing escherichia coli among patients, healthy individuals and in the environment. Indian Journal of Medical Microbiology. 2014; 32(2):172–4.
- Yusha’u M, Abubakar HM, Kawo AH. Commercial drinks as potential sources of Extended Spectrum Beta Lactamases (ESBLs) Producers in Kano, Nigeria. International Journal of Biomedical and Health Sciences. 2010; 1:103–8.
- Johan T. Extended-spectrum beta-lactamase- producing enterobacteriaceae, epidemiology, risk factors, and duration of carriage. Infectious Disease Research Unit. Sweden by Media-Tryck, Lund University; 2012. p. 18–32.
- Blaak H, de Kruijf P, Hamidjaja RA, van Hoek AH, de Roda Husman AM, Schets FM. Prevalence and characteristics of extended spectrum beta lactamase producing e.coli in dutch recreational water influenced by waste water treatment plant. Veterinary Microbiology. 2014; 171(3-4):448–59.
- Rao PNS. Extended spectrum beta lactamases- A comprehensive review. 2015. p. 1–108.
- Rawat D, Nair D. Extended-spectrum β-lactamases in Gram negative bacteria. Journal of Global Infectious Diseases.2010; 2(3):263–74.
- Herbert H, Roger S. Transfer of Extended-Spectrum Β-Lactamase (ESBL)-producers at the human-food chainenvironmentwildlife interface in Switzerland. The APUA Newsletter. 2014; 32(2):5–8.
- Snow LC, Warner RG, Cheney T, Wearing H, Strokes M, Harris K, Teale CJ, Coldham NG. Risk factors associated with extended spectrum beta lactamase producing Escherichia coli [CTX-M] on dairy farms in North West England and North Wales. Preventive Veterinary Medicine.2012; 106(3-4):225–34.
- Rout S, Dubey D, Panigrahy R, Padhy RN. Surveillance of extended-spectrum b-lactamase producing bacteria in an Indian teaching hospital. Journal of Taibah University Medical Sciences. 2014; 9(4):274–81.
- Sahu MC, Dubey D, Rath S, Debata NK, Padhy RN.Multidrug resistance of Pseudomonas aeruginosa as known from surveillance of nosocomial and community infections in an Indian teaching hospital. Journal of Public Health.2012; 20(4):413–23.
- Dubey D, Sarangi R, Debata NK, Padhy RN. Detection of metallo-b-lactamase producing Klebsiella pneumoniae in a neonatal septicemia. Journal of Acute Disease. 2013; 2(1):82–4.
- Rath S, Dubey D, Sahu MC, Padhy RN. Surveillance of ESBL producing multidrug resistant Escherichia coli in a teaching hospital in India. Asian Pacific Journal Tropical Disease. 2014; 4(2):140–9.
- Yasmin T. Prevalence of ESBL among Escherichia coli and Klebsiella spp. in a tertiary care hospital and molecular detection of important ESBL producing genes by multiplex PCR. Department of microbiology and Immunology, Mymensingh Medical Collage, Mymensingh; 2012. p. 159.
- Gillespie SH, Hawkey PM. Principles and practice of clinical bacteriology. 2nd ed. Chichester, England, John Wiley and Sons; 2006. p. 620.
- World Health Organisation WHO. Guide line for drinking water quality; 2001; 82:1–39.
- Sharma P, Sudhir K, Pawas G, Vikas S, Rameshwar S.Antibiotic resistance among commercially available probiotic.Food Research International. 2014; 57:176–95.
- Mishra MP, Debata NK, Padhy RN. Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in India. Asian Pacific Journal Tropical Biomedical.2013; 3(4):315–24.
- Nester E. A human perspective of biotechnology. 4th edn.New York: McGraw Hill; 2004. p. 12338–43.
- Cheesbrough M. District laboratory practice in tropical countries. part 2, 2nd ed. UK: Cambridge University; 2006.p. 35–197.
- Awong-Taylor J, Craven KS, Griffiths L, Bass C, Muscarella M. Comparison of biochemical and molecular methods for the identification of bacterial isolates associated with failed loggerhead sea turtle eggs. Journal of Applied Microbiology.2008; 104(5):1244–51.
- National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing. 12th informational supplement. M100–S12.Wayne PA., National Committee for Clinical Laboratory Standards; 2002.
- Nakamura A, Komatsu M, Noguchi N, Ohno Y, Hashimoto E, Matsutani H, Abe N, Fukuda S, Kohno H, Nakamura F, Matsuo S, Kawano S. Analysis of molecular epidemiologic characteristics of Extended Spectrum Β-Lactamase (ESBL)producing Escherichia coli colonizing faeces in hospital patients and community dwellers in a Japanese city. Journal of Infection and Chemotherapy. 2016; 22(2):102–7.
- Dia ML, Ngom B, Diagne R, Ka R, Lo S, Cisse MF, Arlet G, Sow AI. Molecular detection of CTX-M-15- type β-lactamases in Escherichia coli strains from Senegal. New Microbe and New Infect. 2016; 9:45–6.
- Jarlier V, Nicolas MH, Fournier G, Philippon A.Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae, hospital prevalence and susceptibility pattern. Reviews of Infection Disease. 1988; 10(4):867–78.
- Oyinloye JMA Jnr, Ezekiel CN. Extended-Spectrum Beta-Lactamase (ESBL)-producing multidrug resistant enterobacteria from commercial poultry feeds in nigeria.Annals of Biological Research. 2011; 2(2):250–4.
- Gundogan N, Avci E. Prevalence and antibiotic resistance of Extended Spectrum Beta-Lactamase (ESBL) producing Escherichia coli and Klebsiella species isolated from foods of animal origin in Turkey. African Journal of Microbiology Research. 2013; 7(31):4059–64.
- Rahmani M. Phenotypic and genotypic studies of Extended Spectrum Beta- Lactamase (ESBL) resistance among salmonella isolates from poultry sources in Iran. Iranian Journal of Veterinary Medicine. 2012; 6(4):235–40.
- Chauhan S, Farooq U, Singh V, Ajay K. Determination of prevalence and antibacterial activity of ESBL (Extended Spectrum Beta-Lactamases) producing klebsiella species isolated from raw milk of doon valley in India. International Journal of Pharma and Bio Sciences. 2013; 4(1):417–23.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.